Author: Haber Penina
Publisher: Adis International
ISSN: 0114-5916
Source: Drug Safety, Vol.32, Iss.4, 2009-01, pp. : 309-323
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Clinical Medicine, Vol. 10, Iss. 4, 2010-08 ,pp. :
Guillain-Barré Syndrome: Epidemiology, Pathophysiology and Management
By Kuwabara S.
Drugs, Vol. 64, Iss. 6, 2004-01 ,pp. :
Efalizumab: Guillain-Barré syndrome: case report
Reactions Weekly, Vol. 1, Iss. 1321, 2010-01 ,pp. :